Document Detail

Investigation of Lymphotoxin α Genetic Variants in Migraine.
MedLine Citation:
PMID:  23051989     Owner:  NLM     Status:  Publisher    
Migraine is a common neurological disease with a genetic basis affecting approximately 12 % of the population. Pain during a migraine attack is associated with activation of the trigeminal nerve system, which carries pain signals from the meninges and the blood vessels infusing the meninges to the trigeminal nucleus in the brain stem. The release of inflammatory mediators following cortical spreading depression (CSD) may further promote and sustain the activation and sensitisation of meningeal nociceptors, inducing the persistent throbbing headache characterised in migraine. Lymphotoxin α (LTA) is a cytokine secreted by lymphocytes and is a member of the tumour necrosis factor (TNF) family. Genetic variation with the TNF and LTA genes may contribute to threshold brain excitability, propagation of neuronal hyperexcitability and thus initiation and maintenance of a migraine attack. Three LTA variants rs2009658, rs2844482 and rs2229094 were identified in a recent pGWAS study conducted in the Norfolk Island population as being potentially implicated in migraine with nominally significant p values of p=0.0093, p=0.0088 and p=0.033 respectively. To determine whether these SNPs played a role in migraine in a general outbred population these SNPs were gentoyped in a large case control Australian Caucasian population and tested for association with migraine. All three SNPs showed no association in our cohort (p>0.05). Validation of GWAS data in independent case-controls cohorts is essential to establish risk validity within specific population groups. The importance of cytokines in modulating neural inflammation and pain threshold in addition to other studies showing associations between TNF-α and SNPs in the LTA gene with migraine, suggests that LTA could be an important factor contributing to migraine. Although the present study did not support a role for the tested LTA variants in migraine, investigation of other variants within the LTA gene are still warranted.
Lotta E Oikari; Shani Stuart; Rachel K Okolicsanyi; Hannah C Cox; Sonum Dixit; Rod A Lea; Larisa M Haupt; Lyn R Griffiths
Related Documents :
24521139 - Stress, race, and apoe: understanding the interplay of risk factors for changes in cogn...
24368159 - Neurocognitive and neuropsychiatric phenotypes associated with the mutation l238q of th...
20133659 - Analysis of a gain-of-function fgfr2 crouzon mutation provides evidence of loss of func...
23961259 - Epidermal growth factor receptor mutation in lung adenocarcinoma in india: a single cen...
24587899 - Genes associated with sle are targets of recent positive selection.
24674929 - The association of the bdnf val66met polymorphism and the hippocampal volumes in health...
23300549 - A variant in the abo gene explains the variation in soluble e-selectin levels-results f...
8494999 - Myelodysplastic syndromes: from morphology to molecular biology. part ii. the molecular...
15673729 - Mutations in folp associated with elevated sulfonamide mics for neisseria meningitidis ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-7
Journal Detail:
Title:  Gene     Volume:  -     ISSN:  1879-0038     ISO Abbreviation:  Gene     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7706761     Medline TA:  Gene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Genomics Research Centre, Griffith Health Institute, Griffith University, Gold Coast Campus, Building G05, Griffith University QLD 4222.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Structure-function analysis of the C-3 position in analogues of microbial behavioural modulators HHQ...
Next Document:  Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (E...